{
  "docId": "019dd923-5fec-763b-95cd-961b6879cda6",
  "docSlug": "njj0K6xhOdjDOAwq28MP",
  "documentTitle": "See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech",
  "authorId": "Pitchdecks",
  "authorName": "Moderna",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.29,
  "pageNumber": 4,
  "pageCount": 39,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "The slide uses a table to show historical growth and a text box to frame the industry's 'Risky' and 'Slow/Unscalable' nature.",
  "elementsJson": [
    "action_title",
    "data_table",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cd-961b6879cda6/4",
  "deckHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6#slide-4",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Risky – Probability of success low. Slow/Unscalable. Each molecule demands a unique manufacturing process for research and development.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-d521-73bf-9bb4-698200b5a4aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.15,
        "y": 0.35
      },
      "kind": "image",
      "text": "Small molecule and antibody illustrations",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66be7a72-1845-4367-9172-589291c2cb31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Global Revenues: $1 Trillion",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-d521-73bf-9bb4-6f9ea36906ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.58,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Risky – Probability of success low. Low risk targets are gone. N=1. Each molecule is unique, so few learnings across drug programs. Slow/Unscalable. Each molecule demands a unique manufacturing process for research and development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1eae52af-d10f-4e6b-98d7-d1e8fca71c18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Source: Evaluate Ltd., 01-Nov-2016. Market sizes have been rounded",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3e1e4d8-1333-44f7-8b81-c8a0c58d053f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "table",
      "text": "Global Revenues 1994: $165bn/$10bn; 2004: $425bn/$55bn; 2014: $600bn/$180bn",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64be7e78-1622-40b3-aa92-71a8eec2224c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pharma/Biotech is Massive, with ~$1 Trillion of Sales (2017E) for Small Molecules and Biologics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ada18073-c0c0-4dd0-896a-07a2d2371bfe",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "f5f9dee1-f649-4e19-a768-c78e1c2082e1",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The presentation starts by highlighting the massive pharma/biotech market and the limitations of current technology.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    },
    {
      "to": 5,
      "from": 4,
      "beatId": "7dff0308-6e03-4b8c-a956-0fff1d7a8c32",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The presentation provides market sizing information to highlight the potential opportunity.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}